Back to top

Odyssey Healthcare

Read MoreHide Full Article
Odyssey HealthCare, Inc. (ODSY) estimates are soaring after the most recent earnings surprise.

Company Description

Odyssey Healthcare, Inc. provides hospice care services focused on palliative care for patients with life-limiting illnesses. Care is directed at managing pain and other discomforting symptoms and addressing the psychosocial and spiritual needs of patients and their families.

Another Surprise

Odyssey reported its fifth consecutive earnings surprise on Apr 28. Patient revenue saw a 2.4% bump, to $172 million. Successful expense controls also helped boost earnings.

Net income came in at $13.4 million, up 54% from the same period last year. Earnings per share worked out to 40 cents, topping the Zacks Consensus Estimate by 7 cents.

Estimates Surging

Following the news full-year 2010 estimates jumped to $1.54 on average, from $1.39. Next year's consensus is coming in at $1.65, up 16 cents. The new levels put Odyssey's annual growth rates at 24% and 7%, respectively.

The Chart

Shares of ODSY have been volatile lately, but the overall trend is decisively higher. I am looking for that trend to continue as investors posture for a more uncertain market.

Read the November 6th Feature Here

Odyssey HealthCare, Inc. - ticker ODSY >

Bill Wilton is the Growth Stock Strategist for He is also the Editor in charge of the market-beating Zacks Growth Trader service

Last Week's Aggressive Growth Zacks Rank Buy Stocks

Sirona (SIRO) analysts have raised estimates to the highest level in years, keeping the valuations attractive. Read Full Article.

Valassis Communications (VCI) continues to soar after its latest earnings report. Earnings came in well ahead of expectations and the company raised guidance. Read Full Article.

Cooper Tire & Rubber Co. (CTB) shares set a new 52-week high after its latest quarterly release. Sales, estimates and the outlook are all improving. Read Full Article.

Owens Corning (OC) analysts have drastically increased their estimates, keeping shares fairly priced. With the market weighing on stocks, this could be a good buying opportunity. Read Full Article.

Normally $25 each - click below to receive one report FREE:

More from Zacks Aggressive Growth

You May Like